XPhyto completes Rotigotine transdermal patch optimization and comparative skin absorption study
Oct 11, 2022
Vancouver, Canada, and Uttenweiler, Germany (October 11, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide...